actions

CDC nominee says she won’t betray science — and backs Kennedy’s actions

The Trump administration’s latest nominee to lead the nation’ top public health agency drew frustrated reactions from some U.S. senators on Wednesday when they pressed her on whether she would protect the Centers for Disease Control and Prevention from political meddling.

Dr. Erica Schwartz told the Senate health committee she “will never betray the science” and pledged to use “radical transparency” in a bid to rebuild public trust in the agency. But several senators questioned how she might handle pressure from Health Secretary Robert F. Kennedy Jr., who has repeatedly moved to alter U.S. vaccine and CDC policies. Schwartz repeatedly declined to dissent from some of those actions.

Schwartz, 54, is up for director of the Atlanta-based CDC, which is charged with protecting Americans from preventable health threats.

Her career has largely been spent in military uniform, including in a leadership position at the U.S. Coast Guard where she oversaw the organization’s system of 41 clinics and 150 sick bays — as well as policies promoting vaccinations of service members. She later served as deputy surgeon general, where she helped lead uniformed medical and health professionals posted at the CDC and government health agencies that serve the general public.

The CDC long enjoyed a sterling international reputation but has been in turmoil since Trump returned to office last year. Largely due to layoffs and resignations, the agency has lost more than 3,000 employees, or more than a quarter of its workforce. Morale has plummeted as a succession of mostly temporary leaders have come and gone — the front office filled with political appointees, many of them with little or no training in medicine or public health.

“There’s still really good people who work there (at the CDC). They are doing their best to navigate choppy waters,” said Dr. David Margolius, director of Cleveland’s health department and a leader in a U.S. coalition of big city health departments. But CDC no longer seems to the authoritative and communicative lead that it was on outbreaks and other public health emergencies.

“Basically everybody’s got to kind of choose their own adventure, as opposed to being led by a national public health department,” Margolius said.

CDC has had several leaders

The agency is overseen by Kennedy, who was a leading voice in the anti-vaccine movement before he was tapped to lead the CDC and other federal health agencies. Kennedy had promised not to change the nation’s vaccination schedule. But shortly after taking office, Kennedy said he was going to investigate the childhood vaccine schedule and went on to attempt a substantial rewrite of vaccine recommendations for kids. Some of those efforts were put on hold earlier this year by a federal judge.

The administration’s first pick to run the CDC was former Florida congressman Dr. David Weldon, but his March 2025 Senate confirmation hearing was canceled an hour before it was to begin. Weldon said at the time that he’d been told not enough senators were willing to vote for him.

The White House then moved on to Susan Monarez, who had been serving as the CDC’s acting director. Monarez was confirmed by the Senate, but she was ousted in less than a month. Trump administration officials said she wasn’t aligned with their agenda so they terminated her.

Several key CDC scientific leaders resigned in protest, saying Monarez’s dismissal dashed their hopes that a CDC director would be able to guard against political meddling in the agency’s scientific research and health recommendations.

Since then, there’s been a revolving door in agency leadership, with the short-term role of acting director being passed from one Washington-based HHS official to another. National Institutes of Health Director Jay Bhattacharya has been overseeing the CDC most recently.

Schwartz said she was unaware of actions that hurt the CDC

On Wednesday, some senators suggested Schwartz should follow Monarez’s example, and they asked her about actions Kennedy has taken that have affected CDC.

Schwartz said she was unaware that CDC programs that worked to prevent smoking and promote vaccinations had been curtailed. She declined to commit to taking down a CDC website that suggests there’s a link between childhood vaccines and autism (she said she had not seen it), though she agreed existing medical evidence has not found a link.

Sen. Maggie Hassan, a New Hampshire Democrat, asked if she would — if Kennedy ordered her — suspend promotion of a flu vaccination campaign during a deadly flu season.

“Senator, I don’t speak in hypotheticals,” Schwartz responded.

“It isn’t hypothetical. It happened,” said Hassan, referring to internal CDC emails, released by Sen. Bernie Sanders last month, that documented such a directive from Kennedy to CDC staff last year.

Schwartz said she agreed that CDC should prioritize responding to infectious diseases. “I think over time, the CDC has had some mission creep, and it’s trying to be all things to all people,” she said.

But she also agreed to requests from Republican senators to — if confirmed — look into whether AI data centers cause health problems and into the possibility of establishing a World Trade Center Health Program clinical center in Florida.

Senators also heard from nominee overseeing health emergency preparedness

In April, Trump nominated Schwartz, calling her “incredibly talented.” In a congressional hearing in April, Kennedy said he approved of the choice, but refused to commit to supporting whatever vaccine guidance she might issue.

Last month, Schwartz filed letters with the government that address her finances and potential conflicts of interest. She wrote that if confirmed, she will leave her current job with UnitedHealth Group, where she’s making about $850,000 in salary and bonus money and cash out her stock options. She also will resign from the board of directors of Butterfly Network Inc., a Massachusetts company that makes ultrasound devices; from the board of Atlanta-based Aveanna Healthcare, a medical home care provider; and from the board of the Florida-based Searching for Solutions Institute.

At Wednesday’s hearing, senators also considered the nomination of Sean Kaufman as the Assistant Secretary for Preparedness and Response, or ASPR. That job entails overseeing preparations and response to public health emergencies and disasters.

Last year, the Trump administration announced a plan to bring those responsibilities under CDC, but the dramatic HHS restructuring has not happened.

The assistant secretary’s office is involved in decisions about funding next-generation vaccines against pandemic flu or other infectious disease threats. In postings on LinkedIn, Kaufman has made comments cheered by vaccine skeptics, arguing against hepatitis B vaccinations for newborns and saying he served as an expert witness to advocate for people who refused the COVID-19 vaccine.

On Wednesday, Kaufman faced questions about past social media posts, including one in which he expressed hatred for the CDC. He also repeatedly was asked about his support of a Trump administration decision last year to cancel 22 projects, totaling $500 million, to develop vaccines using mRNA technology.

Infectious disease experts say the mRNA technology used in vaccines is safe, and they credit its development during the first Trump administration with slowing the 2020 coronavirus pandemic. Future pandemics, they warned, will be harder to stop without the help of mRNA.

Kaufman said he supported mRNA technology and believes COVID-19 vaccines are safe and effective, but said it made sense to study work that’s been done so far before, including learning more about any side effects.

Sen. John Hickenlooper, a Colorado Democrat, said such evaluations are the responsibility of other federal offices — not ASPR. He also said it may slow the nation’s ability to respond to emerging new infectious threats.

Stobbe writes for the Associated Press.

Source link

House is set to fund Trump’s immigration actions for the rest of his time in the White House

House Republicans will look to get nearly $70 billion for immigration enforcement over the finish line Tuesday, enough to fund a pair of Homeland Security agencies through the next three years and the rest of President Donald Trump’s time in office.

Speaker Mike Johnson will need near perfect attendance and unity on his side to complete weeks of action on the bill. The legislation got sidetracked when Republicans sought to include $1 billion for enhanced security on the White House grounds, including for Trump’s new ballroom, and the Trump administration tried to create a nearly $1.8 billion fund to compensate allies of the president who claim they have been unjustly investigated and prosecuted. Those proposals proved politically toxic and were scrapped.

Now, the bill is focused entirely on immigration enforcement, a topic that Republicans have treated as a defining issue between the two major political parties and one they hope will carry them to victory in this year’s midterm elections. The bill provides $38 billion for Immigration and Customs Enforcement, $26 billion for the Border Patrol and another $5 billion to cover unforeseen costs, fueling Trump’s deportation agenda.

“It’s long overdue,” said Johnson, R-La., of the bill. “We have to fund border security and immigration enforcement, and it’s sad that Republicans have to do it on our own.”

Funding accelerates Trump’s deportation agenda

The funding comes on top of the nearly $140 billion that the Republican-controlled Congress gave ICE and Customs and Border Protection last year as part of Trump’s tax and spending cuts bill.

Democrats objected to giving the agencies more money without significant changes in the way they operate after the deaths of Alex Pretti and Renee Good in Minneapolis. For example, Democrats insisted that agents be required to display their ID badges during enforcement operations and that they get a judicial warrant before entering private property. Instead, the funding will come with virtually no strings attached.

House Democratic Leader Hakeem Jeffries vowed his party would oppose the package.

“We believe that taxpayer dollars should be used to make life more affordable for the American people – not give ICE another $70 billion blank check so that they can unleash brutality on American citizens and violently target law-abiding immigrant communities,” said Jeffries of New York.

Homeland Security faced longest shutdown in history

The package is the result of a monthslong standoff in Congress after Democrats refused to fund the Department of Homeland Security in the wake of the immigration enforcement actions in Minneapolis and other American cities, leading to the longest shutdown in agency history.

Negotiations had been underway with the White House to alter ICE operations as Democrats were demanding. When those negotiations failed, Republicans turned to a complicated procedural maneuver to get around the filibuster and pass the immigration funding with no Democratic votes.

If approved, the package would next go to Trump for his signature, all but assuring an essentially uninterrupted flow of funds for his immigration enforcement and deportation agenda into 2029.

The Senate completed its work on the legislation last week during an all-night session that extended into the early morning hours Friday. The final 52-47 vote on the bill was nearly party line, with Sen. Lisa Murkowski of Alaska the only Republican to oppose it.

Money comes at pivotal time for immigration agenda

The money will come at a pivotal time for the Department of Homeland Security, which is under new leadership after Trump replaced Kristi Noem with new Secretary Markwayne Mullin in March.

While Mullin has vowed to keep the department out of the headlines, the administration is under pressure from anti-immigration advocates to deliver on Trump’s campaign promise of the largest deportation operation in American history.

So far, the administration has not hit its goal of 1 million deportations a year, but Trump’s border czar, Tom Homan, has promised more to come, including hinting at immigration enforcement actions in New York, the nation’s biggest city, which is heavily Democratic.

At the same time, the administration is making it more difficult for legal immigrants to remain in the U.S. by working to end Temporary Protective Status, changing the processes for obtaining green cards and leaving some Dreamers — the young people who were brought illegally to the U.S. as children — reporting delays in renewing their status, which allows them to stay and work.

Tight vote ahead

On the House side, Johnson has little margin for error. Republicans can afford to lose only a couple of votes if every lawmaker is present. GOP leadership opted to avoid any hiccups and sent lawmakers home last week rather than take up the bill early Friday once the Senate had completed its all-nighter.

The bill is just a slim package, without the hundreds of pages of details and directives that typically come from Congress when it provides funding for agencies.

Leading up to the vote, Democrats portrayed DHS as an agency that has used its new resources to buy private jets for its leadership, warehouse immigrants in deplorable conditions and attack U.S. citizens.

“To give these rogue agencies another $70 billion now when they still have $100 billion in the bank from last year would implicate all of us in the escalating corruption and shameful actions of this department,” said Rep. Jamie Raskin of Maryland, the ranking Democratic member on the House Judiciary Committee.

Republicans countered that they were fulfilling their duty to safeguard the nation and support the men and women charged with enforcing the law.

“Democrats can say whatever they want, but what it’s about is public safety. What’s it about is keeping Americans safe,” said Rep. Michelle Fischbach, R-Minn.

Freking and Mascaro write for the Associated Press.

Source link

Lenz outlines sales force reaching 15,000 eye care professionals by quarter end as VIZZ adoption actions roll out (NASDAQ:LENZ)

Earnings Call Insights: LENZ Therapeutics (LENZ) Q1 2026

Management view

  • “In Q1, our performance was consistent with the expectations we outlined on our last call.” (President, CEO, Secretary & Director Evert Schimmelpennink) “We delivered approximately 25,000 paid and filled prescriptions… and generated $1.9 million in net revenue, including $1.7 million in

Seeking Alpha’s Disclaimer: This article was automatically generated by an AI tool based on content available on the Seeking Alpha website, and has not been curated or reviewed by humans. Due to inherent limitations in using AI-based tools, the accuracy, completeness, or timeliness of such articles cannot be guaranteed. This article is intended for informational purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.

Source link